215 related articles for article (PubMed ID: 7588946)
1. 18FDG PET and acetazolamide-enhanced 99mTc-HMPAO SPET in systemic lupus erythematosus.
Grünwald F; Schomburg A; Badali A; Ruhlmann J; Pavics L; Biersack HJ
Eur J Nucl Med; 1995 Sep; 22(9):1073-7. PubMed ID: 7588946
[TBL] [Abstract][Full Text] [Related]
2. Brain single-photon emission tomography with 99mTc-HMPAO in neuropsychiatric systemic lupus erythematosus: relations with EEG and MRI findings and clinical manifestations.
Colamussi P; Giganti M; Cittanti C; Dovigo L; Trotta F; Tola MR; Tamarozzi R; Lucignani G; Piffanelli A
Eur J Nucl Med; 1995 Jan; 22(1):17-24. PubMed ID: 7698150
[TBL] [Abstract][Full Text] [Related]
3. HMPAO SPET and FDG PET in Alzheimer's disease and vascular dementia: comparison of perfusion and metabolic pattern.
Mielke R; Pietrzyk U; Jacobs A; Fink GR; Ichimiya A; Kessler J; Herholz K; Heiss WD
Eur J Nucl Med; 1994 Oct; 21(10):1052-60. PubMed ID: 7828614
[TBL] [Abstract][Full Text] [Related]
4. The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus.
Kao CH; Lan JL; ChangLai SP; Liao KK; Yen RF; Chieng PU
Eur J Nucl Med; 1999 Feb; 26(2):129-34. PubMed ID: 9933346
[TBL] [Abstract][Full Text] [Related]
5. Cerebellar vascular response to acetazolamide in crossed cerebellar diaschisis: a comparison of 99mTc-HMPAO single-photon emission tomography with 15O-H2O positron emission tomography.
Kuwabara Y; Ichiya Y; Sasaki M; Akashi Y; Yoshida T; Fukumura T; Masuda K
Eur J Nucl Med; 1996 Jun; 23(6):683-9. PubMed ID: 8662103
[TBL] [Abstract][Full Text] [Related]
6. Assessment of cerebral perfusion and cerebrovascular reserve in insulin-dependent diabetic patients without central neurological symptoms by means of 99mTc-HMPAO SPET with acetazolamide.
Jiménez-Bonilla JF; Quirce R; Hernández A; Vallina NK; Guede C; Banzo I; Amado JA; Carril JM
Eur J Nucl Med; 2001 Nov; 28(11):1647-55. PubMed ID: 11702106
[TBL] [Abstract][Full Text] [Related]
7. Regional differences between 99mTc-ECD and 99mTc-HMPAO SPET in perfusion changes with age and gender in healthy adults.
Inoue K; Nakagawa M; Goto R; Kinomura S; Sato T; Sato K; Fukuda H
Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1489-97. PubMed ID: 14579088
[TBL] [Abstract][Full Text] [Related]
8. Regional cerebral blood flow single-photon emission tomography with 99mTc-HMPAO and the acetazolamide test in the evaluation of vascular and Alzheimer's dementia.
Pávics L; Grünwald F; Reichmann K; Horn R; Kitschenberg A; Hartmann A; Menzel C; Schomburg AG; Overbeck B; Csernay L; Biersack HJ
Eur J Nucl Med; 1999 Mar; 26(3):239-45. PubMed ID: 10079314
[TBL] [Abstract][Full Text] [Related]
9. Brain single-photon emission tomography with technetium-99m hexamethylpropylene amine oxime in adolescents with initial-stage schizophrenia.
Batista JF; Galiano MC; Torres LA; Hernández MC; Sosa F; Perera A; Pérez M
Eur J Nucl Med; 1995 Nov; 22(11):1274-7. PubMed ID: 8575476
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive measurements of regional cerebral blood flow using technetium-99m hexamethylpropylene amine oxime.
Matsuda H; Tsuji S; Shuke N; Sumiya H; Tonami N; Hisada K
Eur J Nucl Med; 1993 May; 20(5):391-401. PubMed ID: 8519258
[TBL] [Abstract][Full Text] [Related]
11. Visualization of posture-dependent cerebral blood flow in a patient with Takayasu's disease by means of 99mTc-HMPAO brain single photon emission tomography.
Hayashida K; Nishimura T; Hirose Y; Kaminaga T; Imakita S; Uehara T
Eur J Nucl Med; 1992; 19(11):987-9. PubMed ID: 1358613
[TBL] [Abstract][Full Text] [Related]
12. Cerebral blood flow in Sjögren's syndrome using 99Tcm-HMPAO brain SPET.
Lass P; Krajka-Lauer J; Homziuk M; Iwaszkiewicz-Bilikiewicz B; Koseda M; Hebanowski M; Lyczak P
Nucl Med Commun; 2000 Jan; 21(1):31-5. PubMed ID: 10717899
[TBL] [Abstract][Full Text] [Related]
13. Discrepancy between regional cerebral blood flow and glucose metabolism of the brain in systemic lupus erythematosus patients with normal brain magnetic resonance imaging findings.
Kao CH; Ho YJ; Lan JL; Changlai SP; Liao KK; Chieng PU
Arthritis Rheum; 1999 Jan; 42(1):61-8. PubMed ID: 9920015
[TBL] [Abstract][Full Text] [Related]
14. Increased brain retention of Tc-99m HMPAO following acetazolamide administration.
Burt RW; Witt RM; Cikrit D; Carter J
Clin Nucl Med; 1991 Aug; 16(8):568-71. PubMed ID: 1934809
[TBL] [Abstract][Full Text] [Related]
15. Vascular dementia of Binswanger's type: clinical, neuroradiological and 99mTc-HMPAO SPET study.
Shyu WC; Lin JC; Shen CC; Hsu YD; Lee CC; Shiah IS; Tsao WL
Eur J Nucl Med; 1996 Oct; 23(10):1338-44. PubMed ID: 8781138
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-HMPAO brain SPECT in systemic lupus erythematosus with CNS involvement.
Lin WY; Wang SJ; Yen TC; Lan JL
J Nucl Med; 1997 Jul; 38(7):1112-5. PubMed ID: 9225800
[TBL] [Abstract][Full Text] [Related]
17. [Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings].
Sabri O; Hellwig D; Kaiser HJ; Doherty C; Schneider R; Mull M; Willmes von Hinckeldey KW; Büll U; Thron A; Ringelstein EB
Nuklearmedizin; 1995 Apr; 34(2):50-6. PubMed ID: 7761273
[TBL] [Abstract][Full Text] [Related]
18. Increment of brain temporal perfusion during auditory stimulation. Preliminary study with technetium-99m HMPAO SPET.
Le Scao Y; Baulieu JL; Robier A; Pourcelot L; Beutter P
Eur J Nucl Med; 1991; 18(12):981-3. PubMed ID: 1778211
[TBL] [Abstract][Full Text] [Related]
19. Brain perfusion SPET and proton magnetic resonance spectroscopy in the evaluation of two systemic lupus erythematosus patients with mild neuropsychiatric manifestations.
Colamussi P; Trotta F; Ricci R; Cittanti C; Govoni M; Barbarella G; Giganti M; Bajocchi G; Uccelli L; Trevisan C; Piffanelli A
Nucl Med Commun; 1997 Mar; 18(3):269-73. PubMed ID: 9106782
[TBL] [Abstract][Full Text] [Related]
20. Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in 99mTc-MIBI SPET: a comparative study in patients with coronary artery disease.
Altehoefer C; Kaiser HJ; Dörr R; Feinendegen C; Beilin I; Uebis R; Buell U
Eur J Nucl Med; 1992; 19(5):334-42. PubMed ID: 1612095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
